For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

Dr Rajiv Kovil said, “HFpEF stands as a unique subtype of heart failure, characterized by heart failure symptoms despite a normal or mildly reduced ejection fraction. Remarkably, HFpEF accounts ...

NDAQ:KVAC) Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation ...

Researchers combined data on nearly 4,000 patients across four trials who had heart failure with preserved ejection fraction (or HFpEF) and found that 5.4% of those treated with Wegovy experienced ...

For patients with heart failure with preserved ejection fraction, or HFpEF, the heart muscle contracts properly but the ventricles don’t relax, causing diminished blood flow. Obesity could be a ...

Medera Inc. is a clinical-stage biopharmaceutical company, focused on targeting difficult-to-treat and currently incurable diseases by developing next-generation gene- and cell-based approaches in ...

No randomized controlled trial has yet demonstrated a statistically significant reduction in mortality in HFmrEF or HFpEF, in contrast to HF with reduced EF (HFrEF), the researchers noted in a ...

FINEARTS-HF, she said, “also answers the question definitively” about whether MRAs reduce the risk of cardiovascular death or heart failure events in those with HFmrEF/HFpEF. “We know from other ...

Around half of the seven million heart patients with heart failure in the US have EF that is either mildly ... Also approved for both HFrEF and HFpEF is Novartis’ blockbuster Entresto ...

For patients with HFPEF and other underlying comorbidities ... maximum oxygen consumption <85% of normal value, EF ≥40% with diastolic dysfunction evidence on echocardiogram, exercise for ...